Does CARBOPLATIN Cause Malignant neoplasm progression? 4,177 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 4,177 reports of Malignant neoplasm progression have been filed in association with CARBOPLATIN (Carboplatin). This represents 5.0% of all adverse event reports for CARBOPLATIN.
4,177
Reports of Malignant neoplasm progression with CARBOPLATIN
5.0%
of all CARBOPLATIN reports
1,068
Deaths
971
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CARBOPLATIN?
Of the 4,177 reports, 1,068 (25.6%) resulted in death, 971 (23.2%) required hospitalization, and 199 (4.8%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARBOPLATIN. However, 4,177 reports have been filed with the FAERS database.
What Other Side Effects Does CARBOPLATIN Cause?
Off label use (6,100)
Neutropenia (5,314)
Anaemia (5,312)
Febrile neutropenia (4,888)
Nausea (4,588)
Disease progression (4,538)
Thrombocytopenia (4,483)
Diarrhoea (4,154)
Dyspnoea (3,494)
Drug ineffective (3,377)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
OSIMERTINIB (2,920)
Which CARBOPLATIN Alternatives Have Lower Malignant neoplasm progression Risk?
CARBOPLATIN vs CARBOPROST TROMETHAMINE
CARBOPLATIN vs CARBOXYMETHYLCELLULOSE
CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\GLYCERIN
CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\GLYCERIN\POLYSORBATE 80
CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\HYPROMELLOSES